全文获取类型
收费全文 | 3393948篇 |
免费 | 243132篇 |
国内免费 | 5930篇 |
专业分类
耳鼻咽喉 | 46326篇 |
儿科学 | 110606篇 |
妇产科学 | 92671篇 |
基础医学 | 491036篇 |
口腔科学 | 93377篇 |
临床医学 | 305271篇 |
内科学 | 659336篇 |
皮肤病学 | 75918篇 |
神经病学 | 272549篇 |
特种医学 | 126164篇 |
外国民族医学 | 905篇 |
外科学 | 507399篇 |
综合类 | 73042篇 |
现状与发展 | 15篇 |
一般理论 | 1225篇 |
预防医学 | 271096篇 |
眼科学 | 78280篇 |
药学 | 247400篇 |
11篇 | |
中国医学 | 7225篇 |
肿瘤学 | 183158篇 |
出版年
2021年 | 27772篇 |
2019年 | 28793篇 |
2018年 | 47365篇 |
2017年 | 35413篇 |
2016年 | 39929篇 |
2015年 | 37558篇 |
2014年 | 52665篇 |
2013年 | 78838篇 |
2012年 | 111234篇 |
2011年 | 122814篇 |
2010年 | 73477篇 |
2009年 | 67625篇 |
2008年 | 113707篇 |
2007年 | 121999篇 |
2006年 | 114991篇 |
2005年 | 112864篇 |
2004年 | 108208篇 |
2003年 | 104437篇 |
2002年 | 100094篇 |
2001年 | 151725篇 |
2000年 | 155815篇 |
1999年 | 130312篇 |
1998年 | 38168篇 |
1997年 | 33775篇 |
1996年 | 33752篇 |
1995年 | 31866篇 |
1994年 | 29410篇 |
1993年 | 27602篇 |
1992年 | 99932篇 |
1991年 | 97038篇 |
1990年 | 94338篇 |
1989年 | 90815篇 |
1988年 | 83618篇 |
1987年 | 81642篇 |
1986年 | 76573篇 |
1985年 | 73481篇 |
1984年 | 55167篇 |
1983年 | 46880篇 |
1982年 | 28264篇 |
1979年 | 50393篇 |
1978年 | 35742篇 |
1977年 | 29764篇 |
1976年 | 28425篇 |
1975年 | 30162篇 |
1974年 | 36423篇 |
1973年 | 34761篇 |
1972年 | 32728篇 |
1971年 | 30686篇 |
1970年 | 28573篇 |
1969年 | 27027篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
961.
T. M. Skerry M.D. M.R.C.V.S. R. Suswillo A. J. El Haj N. N. Ali R. A. Dodds L. E. Lanyon 《Calcified tissue international》1990,46(5):318-326
Summary Previous studies of Alcian blue-induced birefringence in adult avian cortical bone showed that a short period of intermittent
loading rapidly produces an increased level of orientation of proteoglycans within the bone tissue. In the absence of further
loading, this persists for over 24 hours. We have proposed that this phenomenon could provide a means for “capturing” the
effects of transient strains, and so provide a persistent, constantly updated strain-related influence on osteocyte populations
related to the bones' averaged recent strain history, in effect, a “strain memory” in bone tissue. In our present study, we
use the Alcian blue-induced birefringence technique to demonstrate that proteoglycan orientation also occurs after intermittent
loading of both cortical and cancellous mammalian bonein vivo andin vitro. We also show that the change in birefringence is proportional to the magnitude of the applied strain, and that the reorientation
occurs rapidly, reaching a maximal value after only 50 loading cycles. Examination of electron micrographs of bone tissue
after staining with cupromeronic blue allows direct visualization and quantification of the change in proteoglycan orientation
produced by loading. This shows that intermittent loading is associated with a realignment of the proteoglycan protein cores,
bringing them some 5 degrees closer to the direction of collagen fibrils in the bone matrix. 相似文献
962.
Bladder mucosa in urethral reconstructions 总被引:6,自引:0,他引:6
963.
964.
Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. 总被引:5,自引:2,他引:3 下载免费PDF全文
Sixteen patients with stable chronic asthma participated in a double blind crossover study comparing the new inhaled long acting beta 2 agonist formoterol with salbutamol. Inhaled (n = 15) and oral steroid (n = 1) treatment were maintained at the same daily dose throughout the study. For four weeks the patients received either formoterol 24 micrograms twice daily or salbutamol 400 micrograms twice daily, plus additional puffs (with the same drug) when needed. Asthma symptoms, additional puffs of beta 2 agonist, peak expiratory flow (PEF), and side effects were recorded daily. During treatment with formoterol the patients used fewer additional puffs of beta 2 agonist, had better symptom scores, less disturbed sleep, more days without additional aerosol, and higher PEF both morning and evening than during salbutamol treatment. Thus formoterol 24 micrograms twice daily gave long lasting bronchodilatation and asthma symptoms were well controlled with regular twice daily administration. 相似文献
965.
966.
967.
968.
969.
Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients 总被引:1,自引:0,他引:1
R H Kerman C T Van Buren R M Lewis V DeVera V Baghdahsarian K Gerolami B D Kahan 《Transplantation》1990,49(1):52-56
We compared our standard NIH (extended incubation) crossmatch (XM) with antihuman globulin (AHG) and flow cytometry XMs and correlated the results with rejection episodes and graft survivals. For 89 CsA-Pred, primary renal allograft recipients, AHG and/or FCXM results did not improve on the NIH-XM-negative (NEG) graft survival results, whether testing pretransplant or historical (Hx) sera. Similarly, there was no association of a positive (POS) AHG or FCXM with increased rejection episodes in these primary recipients. However, for retransplant (Re-Tx) recipients a neg AHG or FCXM did discriminate fewer rejections and an improved graft survival compared with the NIH-XM-neg. results. The overall one-year graft survival for the 47 Re-Tx recipients studied herein was 66% (based on a neg pre-Tx NIH-XM). Pre-Tx AHG-NEG, Re-Tx recipients displayed an improved graft survival compared with NIH-XM NEG recipients (77% vs. 66%, P less than 0.05) and with AHG-POS recipients (77% vs. 47%, P less than 0.05). Similarly, pre-Tx, FCXM-NEG, Re-Tx recipients displayed improved graft survivals compared with NIH-XM-NEG recipients (83% vs. 66%, P less than 0.05) and FCXM-POS recipients (83% vs. 48%, P less than 0.05). Re-Tx recipients displaying a POS AHG and/or FCXM experienced a significantly greater number of rejections than NEG-XM recipients (P less than 0.05, respectively). The AHG and FCXM results correlated with rejections and graft survivals whether testing pre-Tx or Hx high-PRA sera. Re-Tx recipients who were AHG-XM-NEG but FCXM-POS, experienced more rejection episodes than recipients who displayed a negative XM reactivity for both AHG and FCXM (P less than 0.02), but with no resulting differences in graft survival. HLA matching, pre-Tx blood transfusions and PRA did not impact on these crossmatch and graft survival results. Use of AHG and/or FCXMs for Re-Tx, but not primary, recipients should help to improve graft survival for these high-risk recipients. 相似文献
970.
P A Lear 《Transplantation proceedings》1990,22(6):2441-2442